×

Is Valeant worth the risk?

1:08 PM ET Wed, 16 March 2016

Patrick Kaser, Managing Director and Portfolio Manager at Brandywine Global, talks about holding onto Valeant Pharma stocks and his view that a debt default is unlikely.